Ovid Therapeutics (OVID) Capital Expenditures (2016 - 2024)
Ovid Therapeutics (OVID) recorded Capital Expenditures of $22,000 in Q4 2024, up 69.2% from $13,000 a year earlier.
Powered by 
Analysis
Ovid Therapeutics (OVID) Capital Expenditures (2016 - 2024) Analysis & Trends
For FY2024, Ovid Therapeutics reported Capital Expenditures of $71,000, up 77.5% from FY2023.
- Annual Capital Expenditures has a five-year compound annual growth rate of 4.4% (FY2019 to FY2024).
- Across earlier years, Capital Expenditures came in at $40,000 in FY2023 (-96.7%), $1.22 million in FY2022 (+565.4%), $184,008 in FY2021 (+44.6%) and $127,240 in FY2020 (+122.6%).
- Quarterly Capital Expenditures has ranged from -$11,514 in Q2 2021 to $1.04 million in Q2 2022 over the past five years.
- On a year-over-year basis, Capital Expenditures rose in three of the last seven quarters, with growth averaging 23.6%.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 385.7% in Q2 2024, against a decline of 99.3% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -$4,000 (Q3 2024), $34,000 (Q2 2024) and $19,000 (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Ovid Therapeutics | 460.04 Mn | 92.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Jun 30, 2024 | 34,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 14,000.00 |
| Dec 31, 2022 | 119,939.00 |
| Sep 30, 2022 | 18,600.00 |
| Jun 30, 2022 | 1.04 Mn |
| Mar 31, 2022 | 45,935.00 |
| Dec 31, 2021 | 161,958.00 |
| Sep 30, 2021 | 22,050.00 |
| Jun 30, 2021 | -11,514.00 |
| Mar 31, 2021 | 11,514.00 |
| Dec 31, 2020 | 41,883.00 |
| Sep 30, 2020 | 18,305.00 |
| Jun 30, 2020 | 52,913.00 |
| Mar 31, 2020 | 14,139.00 |
API Access
Ovid Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();